Related Experiment Video
Updated: Jun 24, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Clinical aspects of fertility preservation in female patients
Kenny A Rodriguez-Macias Wallberg1, Victoria Keros, Outi Hovatta
1Division of Obstetrics and Gynecology, Fertility Unit, Karolinska University Hospital-Huddinge, Stockholm, Sweden. kenny.rodriguez-wallberg@karolinska.se
Abstract:
There are several methods of fertility preservation available for female patients facing infertility following gonadotoxic treatment of cancer or systemic disease. Embryos, oocytes or ovarian tissue can be cryopreserved and stored until the time when the patient is cured of her main disease and is expecting parenthood. The individual's choice depends on the nature and stage of the main disease, expected treatment, their condition, and age and existence of the partner. It is important to inform all such women about the options, and together with them, choose the most appropriate ones. It is often possible to save ovarian tissue even though the first chemotherapy courses have been undergone, but many more follicles can be stored before cancer treatment.
Related Concept Videos
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Infertility in Males
Menopause
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Oogenesis
Spermatogenesis
